Kintor Pharma Announces 2022 Annual Results and Recent Business Progress

SUZHOU, China, March 30, 2023 /PRNewswire/ -- Kintor Pharmaceutical Limited , a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, today... | March 30, 2023

Related Keywords

China ,Shanghai ,Mugusu ,Guangdong ,Hong Kong ,Jishi ,Peking ,Beijing ,Suzhou ,Jiangsu ,Jilin ,Chinese ,Jianzhong Zhang ,Kintor Pharma ,University People Hospital ,Hong Kong Stock Exchange ,Innovative Pharmaceutical Companies ,Meeting Of Chinese Hair Research Society ,Hong Kong Listed Companies ,Innovation Companies ,Kintor Pharmaceutical ,Prnewswire Kintor Pharmaceutical Limited Pharma ,Rapid Progress On Global Clinical Development ,Pharmaceutical Limited ,Shanghai Hong Kong Stock Connect ,Youzhi Tong ,Global Clinical Development ,Positive Data Read Outs ,Core Products ,Professor Jianzhong Zhang ,Peking University People ,Annual Meeting ,Chinese Hair Research Society ,Proteolysis Targeting Chimera ,Growing Visibility ,Capital Market ,Hong Kong Stock Connect ,Reputable Academic Seminars ,Acute Myeloid Leukemia ,Clinical Lymphoma ,European Journal ,Capital Market Awards ,Kong Listed ,Pharmaceutical Companies ,Innovation Potential List ,Small Molecule Pharmaceutical ,Influential Small Molecule ,Valuable Pharmaceutical ,Business Updates ,Chief Technology Officer ,Entrepreneurship Leading ,Guangdong Province ,Human Resources ,Social Security ,Kintor Pharmaceutical Limited Stock Exchange ,News ,Information ,Press Release ,Arch ,023 ,Pintor ,Harmaceutical ,Imited ,Biotechnology ,Company ,Developing ,Nnovative ,Mall ,Molecules ,End ,Iological 9939 Kyg5273b1077 ,